Leveraging biosimilars to drive savings and support patient access
By the end of 2023, 11 biosimilars for Humira will be available for patients living with inflammatory conditions, enabling lower costs for a drug class that currently represents nearly 25% of total dr...
Read MoreExpress Scripts takes steps to protect Medicare Part D
We believe robust pharmacy networks are critical to ensuring access for Medicare customers and that individual pharmacists deserve the opportunity to make the decision that’s best for their business.
Read MoreImproving Access to Safe and Affordable Medications for Rural Communities
For over 35 years, Express Scripts has worked to ensure that Americans receive safe, affordable pharmacy care – no matter where they live.
Read MoreExpress Scripts launches new initiative to expand rural health care access through partnerships with independent pharmacies
Express Scripts announced key efforts to expand access to health care in rural communities through partnerships with independent pharmacies across the U.S.
Read MoreDrug Lists 101 – Supporting Access to Safe and Effective Medications
Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.
Read MoreMeet Adam Kautzner, President of Express Scripts
Adam Kautzner has deep expertise in pharma relations, formulary development, value-based solutions, and pharmacy network contracting. He was recently named president of Express Scripts, the pharmacy b...
Read More